{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:49:07Z","timestamp":1782258547611,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10620-024-08583-7","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T20:19:06Z","timestamp":1723321146000},"page":"4430-4436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of a Hand-Held Point-of-Care Device to Measure Breath Hydrogen and Its Utility in Detecting Response to Antibiotic Treatment"],"prefix":"10.1007","volume":"69","author":[{"given":"Guillermo","family":"Barahona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Mc Bride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ine","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Villatoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Treisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj J.","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"key":"8583_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","volume":"396","author":"CJ Black","year":"2020","unstructured":"Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet (London, England). 2020;396:1664\u20131674.","journal-title":"Lancet (London, England)."},{"key":"8583_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160:99-114.e3.","journal-title":"Gastroenterology."},{"key":"8583_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fcimb.2020.00468","volume":"10","author":"C Carco","year":"2020","unstructured":"Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 2020;10:468.","journal-title":"Front Cell Infect Microbiol."},{"key":"8583_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jgh3.12528","volume":"5","author":"L Wei","year":"2021","unstructured":"Wei L, Singh R, Ro S, Ghoshal UC. Gut microbiota dysbiosis in functional gastrointestinal disorders: underpinning the symptoms and pathophysiology. JGH Open. 2021;5:976\u2013987.","journal-title":"JGH Open."},{"key":"8583_CR5","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1038\/s41598-018-22408-4","volume":"8","author":"RB Jones","year":"2018","unstructured":"Jones RB, Zhu X, Moan E et al. Inter-niche and inter-individual variation in gut microbial community assessment using stool, rectal swab, and mucosal samples. Sci Rep. 2018;8:4139.","journal-title":"Sci Rep."},{"key":"8583_CR6","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41467-019-09964-7","volume":"10","author":"GB Saffouri","year":"2019","unstructured":"Saffouri GB, Shields-Cutler RR, Chen J et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat Commun. 2019;10:2012.","journal-title":"Nat Commun."},{"key":"8583_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jand.2019.05.015","volume":"120","author":"L Wang","year":"2020","unstructured":"Wang L, Alammar N, Singh R et al. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. J Acad Nutr Diet. 2020;120:565\u2013586.","journal-title":"J Acad Nutr Diet."},{"key":"8583_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40168-021-01018-9","volume":"9","author":"J Tap","year":"2021","unstructured":"Tap J, St\u00f6rsrud S, Le Nev\u00e9 B et al. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome. Microbiome. 2021;9:74.","journal-title":"Microbiome."},{"key":"8583_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5056\/jnm.2010.16.3.299","volume":"16","author":"S Kumar","year":"2010","unstructured":"Kumar S, Misra A, Ghoshal UC. Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil. 2010;16:299\u2013305.","journal-title":"J Neurogastroenterol Motil."},{"key":"8583_CR10","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/j.1440-1746.2010.06370.x","volume":"25","author":"DK Ong","year":"2010","unstructured":"Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1366\u20131373.","journal-title":"J Gastroenterol Hepatol."},{"key":"8583_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2018.1460013","volume":"10","author":"AA Fodor","year":"2019","unstructured":"Fodor AA, Pimentel M, Chey WD et al. Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome. Gut Microbes. 2019;10:22\u201333.","journal-title":"Gut Microbes."},{"key":"8583_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/CEG.S89999","volume":"8","author":"S Soldi","year":"2015","unstructured":"Soldi S, Vasileiadis S, Uggeri F et al. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach. Clin Exp Gastroenterol. 2015;8:309\u2013325.","journal-title":"Clin Exp Gastroenterol."},{"key":"8583_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","volume":"53","author":"J Yang","year":"2008","unstructured":"Yang J, Lee HR, Low K, Chatterjee S, Pimentel M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci. 2008;53:169\u2013174. https:\/\/doi.org\/10.1007\/s10620-007-9839-8","journal-title":"Dig Dis Sci."},{"key":"8583_CR14","first-page":"143","volume":"51","author":"IG Moraru","year":"2013","unstructured":"Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitra\u015fcu DL. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study. Rom J Intern Med. 2013;51:143\u2013147.","journal-title":"Rom J Intern Med."},{"key":"8583_CR15","unstructured":"Bae S, Lee KJ, Kim YS, Kim KN. Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects. J Korean Med Sci."},{"key":"8583_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. Am J Gastroenterol. 2017;112:775\u2013784.","journal-title":"Am J Gastroenterol."},{"key":"8583_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","volume":"3","author":"NM Buderer","year":"1996","unstructured":"Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996;3:895\u2013900.","journal-title":"Acad Emerg Med."},{"key":"8583_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5056\/jnm19113","volume":"26","author":"G Losurdo","year":"2020","unstructured":"Losurdo G, Leandro G, Ierardi E et al. Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil. 2020;26:16\u201328.","journal-title":"J Neurogastroenterol Motil."},{"key":"8583_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jgh.14938","volume":"35","author":"UC Ghoshal","year":"2020","unstructured":"Ghoshal UC, Nehra A, Mathur A, Rai S. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. J Gastroenterol Hepatol. 2020;35:922\u2013931.","journal-title":"J Gastroenterol Hepatol."},{"key":"8583_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(98)02146-1","volume":"352","author":"TS King","year":"1998","unstructured":"King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998;352:1187\u20131189.","journal-title":"Lancet."},{"key":"8583_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1046\/j.1365-2036.2000.00808.x","volume":"14","author":"M Di Stefano","year":"2000","unstructured":"Di Stefano M, Strocchi A, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther. 2000;14:1001\u20131008.","journal-title":"Aliment Pharmacol Ther."},{"key":"8583_CR22","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/j.1572-0241.2000.02189.x","volume":"95","author":"A Koide","year":"2000","unstructured":"Koide A, Yamaguchi T, Odaka T et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:1735\u20131741.","journal-title":"Am J Gastroenterol."},{"key":"8583_CR23","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s10620-011-1569-2","volume":"56","author":"YH Youn","year":"2011","unstructured":"Youn YH, Park JS, Jahng JH et al. Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. Dig Dis Sci. 2011;56:2059\u20132066.https:\/\/doi.org\/10.1007\/s10620-011-1569-2","journal-title":"Dig Dis Sci."},{"key":"8583_CR24","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","volume":"310","author":"T Ringel-Kulka","year":"2016","unstructured":"Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol. 2016;310:G417\u2013G426.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"8583_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","volume":"133","author":"A Kassinen","year":"2007","unstructured":"Kassinen A, Krogius-Kurikka L, M\u00e4kivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24\u201333.","journal-title":"Gastroenterology."},{"key":"8583_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234906","volume":"15","author":"G Leite","year":"2020","unstructured":"Leite G, Morales W, Weitsman S et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. PLoS One. 2020;15:e0234906.","journal-title":"PLoS One."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08583-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:10:46Z","timestamp":1732727446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08583-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8583"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08583-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u00c1ine Moran, Barry Mc Bride, and Ricky Harrison are employees of FoodMarble Digestive Health. Pankaj Jay Pasricha is a member of the clinical advisory board of FoodMarble Digestive Health and a paid consultant. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}